EUVIMEDEUVIMED entdecken
Crossref

Antibacterial Fusobacterium nucleatum ‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer

Linfu Chen, Rui Zhao, Jingjing Shen, Nanhui Liu, Zixuan Zheng, Yu Miao, Jiafei Zhu, Lin Zhang, Yingyao Wang, Huapan Fang, Jun Zhou, Maoyi Li und 3 weitere

Advanced Materials · 2023-11 · 35 (45)

DOI: 10.1002/adma.202306281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 02.10.2023. Verfasst von Linfu Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow Universit…. Hauptthemen laut MEDLINE: Fusobacterium nucleatum, Colorectal Neoplasms. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Suzhou Key Laboratory of Nanotechnology and Biomedicine, Collaborative Innovation Center of Suzhou Nano Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical evidence indicates that tumor‐colonizing bacteria can be closely related to the tumor development and therapeutic responses. Selectively eliminating bacteria within tumors may be an attractive approach to enhance cancer treatment without additional side effects. Herein, it is found that, owing to the high affinity between the membrane protein Fap‐2 on Fusobacterium nucleatum and d ‐galactose‐β (1‐3)‐ N ‐acetyl‐ d ‐galactosamine (Gal‐GalNAc) overexpressed on colorectal tumor cells, F. nucleatum can colonize in colorectal tumors, as evidenced by both clinical samples and animal tumor models. Notably, F. nucleatum colonized in colorectal tumors can lead to an immunosuppressive tumor microenvironment, greatly reducing their responses to immune checkpoint blockade (ICB) therapy. Inspired by this finding, an F. nucleatum ‐mimetic nanomedicine is designed by fusing F. nucleatum cytoplasmic membrane (FM) with Colistin‐loaded liposomes to achieve selective killing of tumor‐colonizing F. nucleatum without affecting gut microbes. As a result, the therapeutic responses of F. nucleatum ‐colonized tumors to ICB therapies can be successfully restored, as demonstrated in an F. nucleatum ‐infected subcutaneous CT‐26 tumor model, chemically induced spontaneous colorectal cancer models, and MC‐38 tumor model. In summary, this work presents an F. nucleatum ‐mimicking nanomedicine that can selectively eliminate tumor‐colonized bacteria, which is promising for enhancing the responses of cancer immunotherapy against F. nucleatum ‐colonized colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fusobacterium nucleatumColorectal NeoplasmsAnimalsNanomedicineAnti-Bacterial AgentsImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

Fusobacterium nucleatumbiomimetic nanomedicinecolorectal cancerimmunoresistencetargeted drug delivery

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, 215123, P.R. China.
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, P.R. China.
  • Department of Gynecologic Oncology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P.R. China.
  • Department of Gynecology, Kunshan Maternity and Children's Health Care Hospital, Suzhou, Jiangsu, 215300, P.R. China.

ORCID-Profile: Qian Chen

Förderung

  • National Natural Science Foundation of China
  • Suzhou Key Laboratory of Nanotechnology and Biomedicine
  • Collaborative Innovation Center of Suzhou Nano Science and Technology
  • The 111 Program from Ministry of Education of China
  • National Research Programs of China

Zitieren

APA

Chen, L., Zhao, R., Shen, J., Liu, N., Zheng, Z., Miao, Y., Zhu, J., Zhang, L., Wang, Y., Fang, H., Zhou, J., Li, M., Yang, Y., Liu, Z., & Chen, Q. (2023). Antibacterial Fusobacterium nucleatum ‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer. Advanced Materials, 35(45). https://doi.org/10.1002/adma.202306281

Vancouver

Chen L, Zhao R, Shen J, Liu N, Zheng Z, Miao Y, et al. Antibacterial Fusobacterium nucleatum ‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer. Advanced Materials. 2023;35(45). doi:10.1002/adma.202306281

BibTeX
@article{Chen2023,
  author = {Chen, Linfu and Zhao, Rui and Shen, Jingjing and Liu, Nanhui and Zheng, Zixuan and Miao, Yu and Zhu, Jiafei and Zhang, Lin and Wang, Yingyao and Fang, Huapan and Zhou, Jun and Li, Maoyi and Yang, Yang and Liu, Zhuang and Chen, Qian},
  title = {Antibacterial Fusobacterium nucleatum ‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer},
  journal = {Advanced Materials},
  year = {2023},
  volume = {35},
  number = {45},
  doi = {10.1002/adma.202306281}
}
Kostenlos starten →